Inhibits de novo palmitate synthesis in CRC (343).Supresses denovo lipogenesis in BC (82, 344, 345).Form a covalent bond with the enzyme FASN and inhibits its function, thereby inhibiting lipogenesis in PC (419–421). The gene discussed is FASN; the disease is breast cancer.